Navigation Links
Lo studio pubblicato su European Radiology esalta ulteriormente l'utilizzo della tomosintesi al seno di Hologic nell'ambito dello screening del cancro con utilizzo della doppia lettura
Date:4/22/2013

risultati del presente studio  rafforzino  ulteriormente l'adozione della nostra tecnologia di tomosintesi".

L'articolo di European Radiology rappresenta la prima pubblicazione a revisione paritaria che confronta i risultati degli esami 2D a doppia lettura con la doppia lettura del 2D abbinata all'imaging di tomosintesi in un grande trial clinico prospettico.

La tecnologia di tomosintesi al seno di Hologic è approvata dal 2008 nei Paesi che riconoscono il marchio CE. Negli Stati Uniti è stata approvata a Febbraio del 2011 per l'utilizzo nello screening e nella clinica per la diagnosi del cancro al seno. I sistemi Hologic sono attualmente in uso in 48 Stati negli Stati Uniti e in oltre 50 Paesi.

Per maggiori informazioni sulla tecnologia di tomosintesi al seno di Hologic, visitare il sito Web http://www.breasttomo.com/ (per operatori sanitari) e http://www.hologic3d.com/ (per pazienti).

Informazioni su Hologic, Inc.Hologic, Inc. è leader nello sviluppo, nella produzione e nella fornitura di prodotti diagnostici, sistemi medici di acquisizione delle immagini e di prodotti chirurgici di alta qualità. La Società gestisce quattro unità aziendali chiave concentrate sulla diagnostica, sulla salute del seno e sulla salute scheletrica e chirurgica in ambito ginecologico. Con una gamma completa di tecnologie e un efficace programma di ricerca e sviluppo, Hologic è impegnata nel miglioramento della vita. La Società ha sede nel Massachusetts (USA).

Hologic è un marchio e/o marchio registrato di Hologic, Inc., e/o delle sue consociate negli Stati Uniti e/o in altri Paesi.

Dichiarazione previsionale di non responsabilità.Questo comunicato stampa potrebbe contenere informazioni previsionali che implicano rischi e incertezze, incluse le dichiarazioni circa l'utiliz
'/>"/>

SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
2. Anthony Creed Joins DDSTUDIO As GM, Experience Design
3. Study Published in European Radiology Further Supports the Use of Hologics Breast Tomosynthesis in Cancer Screening in Practices Using Double Reads
4. Moravia Provides Guidance to Life Sciences Sector as Croatia Nears EU Accession and European Medicines Agency Deadlines Loom
5. Fifteen Pioneering Inventors Nominated for European Inventor Award
6. European Dental Biomaterial Revenues Will Grow To Over $375 Million In 2021, In Line With Rising Dental Implant Placements
7. Western European Endoscopic Devices Market to Benefit from Increase in Minimally Invasive Surgeries, Says Frost & Sullivan
8. European Nuclear Medicine / Radiopharmaceuticals Market Worth by Reach $1.6 Billion by 2017
9. SonaCare Medical Successfully Launches New Products at European Association of Urology (EAU)
10. N30 Pharma Announces Presentation of Preclinical Data at the Basic Science Meeting of the European Cystic Fibrosis Society
11. Chimerixs Antiviral CMX001 Abstract Selected for an Oral Presentation at the European Group for Blood and Marrow Transplantations Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015  Dr. Cal Robinson , Psy.D., ... Center today, providing patients with new methods ... through psychological counseling and treatment programs. ... medical psychologist with an extensive career in pain ... from assessment and treatment of behavioral medicine disorders ...
(Date:8/3/2015)... ANGELES, Aug. 3, 2015  CytRx Corporation (NASDAQ: ... in oncology, today reported financial results for the three ... overview of recent accomplishments and upcoming milestones for its ... 2015 has been very productive for CytRx. Enrollment in ... aldoxorubicin in soft tissue sarcoma (STS) continues on track ...
(Date:8/3/2015)... FREDERICK, Md. , Aug. 3, 2015  BioElectronics ... products for pain management, announced that Andrew J. ... Taylor on his program "On Business" at 9am ... to the interview live, tune to: ... to report on the exceptional acceptance the company,s flagship ...
Breaking Medicine Technology:Orthopaedic & Spine Center Introduces New Pain Psychologist 2CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2
... 30 Wound Care,Innovations, LLC, a subsidiary of ... today that it will attend and exhibit at,the ... Boston. This,seminar is presented by HMP Communications, the ... and producers of the Symposium on,Advanced Wound Care. ...
... NIH; Findings could benefit,pregnant women worldwide, SEATTLE, ... and Human Development division of the National Institutes ... a $2.9 million grant,for a five-year research project ... known as preeclampsia and migraine., Dr. Williams ...
Cached Medicine Technology:Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R) 2Swedish in Seattle to Study Connections Between Preeclampsia and Migraine 2Swedish in Seattle to Study Connections Between Preeclampsia and Migraine 3
(Date:8/3/2015)... ... August 03, 2015 , ... They know every second ... St. Vincent Medical Center offers some of the best care in the nation. For ... neurointerventionalist, achieved the fastest average blood clot removal time in the country. During the ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... to contract research organisations (CROs) for a slew of benefits, allowing them to ... and operations, boost quality with cost-effective utilisation of resources, get access to innovation ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... services to help patients in need. Most people know that general health emergencies, such ... Unfortunately, a fewer amount of people know where to turn to during a dental ...
(Date:8/3/2015)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions ... Wednesday, August 12, 2015 at 9:45am (ET) at Le Parker Meridien in New York, ... be accessed via the investor relations section of the Company’s website. , About AxoGen, ...
(Date:8/3/2015)... , ... August 03, 2015 , ... A July 13 ... of Stem Cells Found to Release Natural Painkiller That Can Last 'For Five Weeks'" ... According to the report, the new study showed that harvesting stem cell-rich bone marrow ...
Breaking Medicine News(10 mins):Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3
... Ekahau Positioning Engine and Tags With ... Room Personnel, SARATOGA, California, July 30 Ekahau ... (RTLS), today announced,that the 12 de Octubre Hospital in ... is designed to improve security,and safety of its emergency ...
... 29 Microtest Laboratories has,launched a suite of ... U.S. that have yet failed to meet mandatory ... also announced,its offer of a free facility-gap-analysis audit ... level and corresponding,preparation., Pharmacies failing to comply ...
... Company,(NYSE: KVa/KVb), today reported that it is set ... -- principally cough/cold products -- previously,sold by ETHEX ... previously disclosed discussions with the FDA regarding the,agency,s ... by,ETHEX as well as other pharmaceutical companies for ...
... Challenge, SACRAMENTO, Calif., July 29 As ... Next 10 has just released,a newly updated version ... try their hand at dealing with the tradeoffs ... 2008 Budget Challenge, an online,interactive educational game, contains ...
... Pro Forma EPS Guidance, BETHESDA, Md., July 29 ... of $181.2 million for the,quarter ended June 30, 2008 an ... quarter. Net income increased by $2.9 million, or,57.2%, to $8.0 ... same,quarter last year., Pro forma net income applicable to ...
... LITTLE ROCK, Ark., July 29 Heifer International ... corporate partnership,agreement. Heifer International is a world hunger ... Greenfield, Indiana, that has,offices in 30 countries around ... improve animal health and productivity., The partnership ...
Cached Medicine News:Health News:Madrid Hospital Improves Employee Safety With Ekahau Wi-Fi RTLS 2Health News:Madrid Hospital Improves Employee Safety With Ekahau Wi-Fi RTLS 3Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 3Health News:KV Set to Dispose of Previously Written Off Guaifenesin Inventory 2Health News:KV Set to Dispose of Previously Written Off Guaifenesin Inventory 3Health News:As Budget Stalemate Wears On - Voters Can Set Their Own Priorities 2Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 2Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 3Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 4Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 5Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 6Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 7Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 8Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 9Health News:Hanger Orthopedic Group, Inc. Beats First Call Q2 EPS Estimates by $0.05 on 13% Sales Growth and 57.2% Growth in Net Income 10Health News:Heifer and Elanco Announce Charitable Partnership 2